Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple Sclerosis. Subei AM, Ontaneda D CNS Drugs. 2015 Sep; 29(9):759-71. PMID: 26407624. Abstract CommentRecommendBookmarkWatch